Longer intervals and extra doses of ChAdOx1 nCoV-19 vaccine

Lancet. 2021 Sep 11;398(10304):933-935. doi: 10.1016/S0140-6736(21)01817-1. Epub 2021 Sep 1.

Authors

Elizabeth T Rogawski McQuade¹, Alexander Breskin²

Affiliations

¹ Department of Public Health Sciences, University of Virginia, Charlottesville, VA, USA; Department of Epidemiology, Emory University, Atlanta, GA 30322, USA. Electronic address: erogaws@emory.edu.
² NoviSci, Durham, NC, USA; Department of Epidemiology, University of North Carolina at Chapel Hill, Chapel Hill, NC, USA.

No abstract available

Publication types

Research Support, N.I.H., Extramural
Comment

MeSH terms

COVID-19 Vaccines
COVID-19*
ChAdOx1 nCoV-19
Humans
SARS-CoV-2
Vaccines*

Substances

COVID-19 Vaccines
Vaccines
ChAdOx1 nCoV-19

Grants and funding

K01 AI130326/AI/NIAID NIH HHS/United States